ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Non-verbal dichotic listening: A new cognitive hearing test for dementia.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionCentral hearing difficulties are a feature of Alzheimer's disease (AD) but not well captured by standard speech perception tests.
methodsWe developed a non-verbal dichotic listening test (NVDLT) based on everyday sounds, and compared this with a standard verbal dichotic listening test (VDLT) in 36 people with primary progressive aphasia (PPA), 18 with typical AD (tAD), 6 with right temporal-variant frontotemporal dementia (rtvFTD), and 29 cognitively-healthy controls. Daily-life hearing function was assessed using the modified Amsterdam Inventory for Auditory Disability and Handicap (mAIAD).
resultsOn NVDLT, all dementia groups except rtvFTD performed worse than controls; tAD, logopenic-variant PPA and nonfluent/agrammatic-variant PPA performed worse than rtvFTD. NVDLT performance predicted atrophy in the retrosplenial cortex and hippocampus. NVDLT score discriminated tAD patients from controls with near-perfect accuracy (area under the curve [AUC] = 0.99) and predicted daily-life hearing function (r = 0.57). DISCUSSION: NVDLT performance indexes daily-life hearing function and may aid dementia diagnosis, potentially in culturally-diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.